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Abstract 
Objectives 
To report on trends of tuberculosis ascertainment among HIV patients in a rural HIV cohort 
in Tanzania, and assessing the impact of a bundle 01 services implemented in December 
2012. consisting of three components:(i)integration of HIV and tuberculosis services; (ii) 
GeneXpert for tuberculosis diagnosis; and (iii)electronic data collection. 
Design 
Retrospective cohort study of patients enrolled in the Kilombero Ulanga Antiretroviral Co· 
hart (KIULARCO), Tanzania.) 
Methods 
HIV patients without prior history of tuberculosis enrolled in the KIULARCO cohort between 
2005 and 2013 were included. Cox proportional hazard models were used to estimate rates 
and predictors of tuberculosis ascertainment 
Results 
Of 7114 HIV positive patients enrolled, 5123(72%) had no history of tuberculosis. Of these, 
66% were female, median age was 38 years, median baseline CD4+ cell count was 243 
cells/~l, and 43% had WHO clinical stage 3 or 4. During follow·up, 421 incident tuberculosis 
cases were notified with an estimated incidence of 3.6 per 100 person·years(p-y)[95% con-
fidence interval(CI)3.26·3.97). The incidence rate varied over time and increased 
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A Bundle of Services for TB-HIV ascertainment in Rural Africa 
significanlly from 2.96 to 43.98 cases per 100 p-y after the introduction of the bundle of ser-
vices in December 2012. Four independent predictors of tuberculosis ascertainment were 
identified:poor clinical condition at baseline (Hazard Ratio (HR) 3.89, 95% CI 2.87-5.28), 
WHO clinical stage 3 or 4 (HR 2.48,95% CI1.88-3.26), being antiretroviralna"lve (HR 2.97, 
95% CI 2.25-3.94), and registration in 2013(HR 6.07, 95% CI4.39-8.38). 
Conclusion 
The integration of tuberculosis and HIV services together with comprehensive electronic 
data collection and use of GeneXpert increased dramatically the ascertainment of tubercu-
losis in this rural African HIV cohort. 
Introduction 
T uberculosis (TB) remains the most cOlllmon opportun istic infection among HIV-infected pa-
tients. in particular in sub-Saharan Africa (SSA), and can occur at any stage of HI V disease [1]. 
According to recent studies and reports from Tanzania, about 10% of alll-BV -infected individ-
uals develop act ive TB[~] whereas nearly half ofTB patients are co- infected with HIV[3], 
Trends ofTB notification in Africa have decreased over time[1-QJ. which has been mostly 
attributed to improved screening and provision of antiret rovi ral therapy (ART) among 
TB-HIV infected individuals {!!.6]. However, TB cases per population in SSA are st ill highest 
compared to other regions [4]. Lack of widely available point of care robust tools for TB diag-
nosis. high prevalence of HI V infection. and challenges in reporting ofTI3 remain obstacles for 
TB control in SSA[1J Moreover. d iagnosis ofTB in SSA often relies on the use of microscopy. 
radiological findings and clinical symptoms, and in most cases culture is not rout inely per-
formed due to minimal capaci ty and lack of infrastructure[I.Sl. 
In December 2012, the Chronic Disease Clinic ofifakara (CDCI) situated within the Saint 
Francis Referral Hospital (SFRH) in Ifakara, south-central Tanzania. introduced a bundle of 
services to optimize the funct ioning of the clinic in general and the diagnosis and management 
ofTB-HIV cases in particular. This bundle of services consisted of three main components, 
namely the integration ofTI3 and HIV services within one single faci li ty. the use ofGeneXperl 
(Cepheid, Sunnyvale CA) for TB diagnosis. and the introd uction of an electronic data collec-
tion system. 
Several studies have shown independent effectiveness of each of these strategies [2.-22]. The 
"VHO recommends integrating service delivery. use of point of care diagnosiS. and replacing of 
paper clinic logs with electronic medical records. We hypothesized that the implementation of 
this bundle of services in our rural HIV cohort in Tanzania in December 20 12 may have in-
creased the rate ofTB ascertainment. 
Methods 
Study design and setting 
We conducted a retrospective cohort study using the KIULARCO cohort database between 
2005 and 20 13. This cohort is comprised of all patients visited at the Chronic Diseases Clinic of 
Ifakara. Morogoro. southern Tanzania, who give their informed consent to participate. Details 
of the KIULARCO cohort are given e1sewhere[23,24]. 
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Participants 
We included all patients enrolled in KIULARCO between 2005 and 201 3. Exclusion criteria in-
cluded:(i) reported history ofTB; (ii) lack of fo llow-up informa tion: and (iii) referral fro lll a TB 
clinic. The KIULARCO studywasreviewed and approved by the IfakaraHealthInstitute (IHI) 
institutional reviewboard and the National Institute for MedicalResearch (NIMR) of Tanzania. 
Informed consent to participate in the KIULARCO cohort is sought from all patients upon reg-
istrat ion in the Chronic Diseases Clin ic ofIfakara. Regular supply of ART was introduced in 
our clinic in 2005. 
Variables and data source 
Outcome. The outcome variable was TB recording in the KIULARCO database during the 
follow-up period, defined as having one of the following recorded in the database: 1) TB diag-
nosis, 2) positive sputum smear, 3) positive GeneXpert in sputum or other extra pulmonary 
sample 4) chest X-ray suggestive ofT6 together with at least one reported symptom ofTB, or 
5) having been treated with anti-tuberculosis drugs. We included both pulmonary and ext ra-
pulmonary TB cases. Before the introduction of the electronic medical record in December 
2012, data was collected using paper-based questionnaires filled by the cl inicians at each visit 
and double data entered in anelectronic database by 2 data clerks. The structure of the ques-
tionnaire was entirely based on the patient record form of the Tanzanian National AIDS Con-
trol Program. Q uestions specifically concerning TB included screening questions (cough, 
weight loss, chronic fever. fatigue, night sweats), and TB diagnosis (yes/no/diagnosed today). 
Predictors of tuberculosis ascertainment. The potential explanatory variables for tuber-
culosis ascertainment assessed included sex. age. marital status, baseline CD4 counts. WHO 
clinical stage, ART treatment , smoking. history of chron ic illness (cancer. diabetes, hyperten-
sion), period of registration, and fun ctional status. All variables were obta ined from the KIU-
LARCO cohort database. 
Definitions 
Integration ofTB and HIV within one facility. Before the introduction of the bundle of 
services, the TB and HIV care and treatment serv ices at Saint Francis Referral Hospital were 
running in parallel and patients were referred between the two facilities. Integration of1'B and 
HIV se rvices included bringing aU services under one facility. After the start of the bundle of 
service HIV patients are systematically screened for TB symptoms at each vis it and, in turn, all 
pa tients diagnosed with TB a re screened for HIV. Clin icians specifically ask for TB symptoms 
using the World Health Organization (WHO) symptom screening tool [£~] and request a 
chest radiography and sputum smear for bac illoscopy+/- GeneXpert analys is if sympto ms of 
pulmonary tuberculosis are detected. Treatments of both diseases are provided at the same in-
tegrated HIV-TB clinic, under the same roof. and by the same medical staff. All staffs at the 
CDCI underwent training on sc reening ofTB among HIV, HIV among TB. infection control 
as well as procedural changes at the clinic to accommodate new system changes. In addition, 
two differen t wait ing areas and entrance to the cl inic as well as two different sites fo r drug dis-
pensing were accommodated to avoid contact between TB and HIV patients. 
Use of GeneXpert. GeneXpert was introduced in order to improve timely detection and di -
agnosis ofTB among individuals with or without diagnosis ofHIV. Sputum or extra-pulmonary 
samples are obtained from TB suspects when feasible. Results are made available to the clinic 
within two hours and treatment is sta rted immediately in case of a positive result. 
Use of electronic data collection system. Previously ex isting case report fo rms (eRF) 
were optimised to include all detailed visit information, concerning medical history, phys ical 
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examination and diagnoses using International Classification of Diseases (ICD)-IO codes, ART 
toxicity. drug prescription and refill information, as well as laboratory results. An electronic 
medical record system was then developed based on these new CRFs using the Open MRS plat-
fOfm (lillp:l/or~£nmrs.ol'gD and all paper forms were fully rep laced. The system, designed to 
comprehensively capture all clinically relevant information and minimising missing data and 
data entry mistakes, was launched in December 2012 and has been used without interruption 
at the CDCI ever since. 
Statistical methods 
I3aseline characteristics wefe summarized as proportions/percentages for categorical variables 
and medians and in terquartile ranges for continuous variables. Annual specific notification in-
cidence rates, cumulative incidence rates pre- and during 20 13, and incidence rates by selected 
variables were calculated using Cox proportional hazard model. Estimated number ofTB 
cases, person-years incidence rates and 95% confidence interval (Cl) were presented. In addi-
tion, the incidence of ea rl y tuberculosis ascertainment was assessed by separately calculating 
the rate of tuberculosis ascertainment in those diagnosed within a month of registra tion , 
Cox proportional hazard models were used to dete rmine independent predictors of tubercu-
losis ascertainment in order to assess the impact of the bundle of se rvices introduced in Decem -
ber 2012. Hazard ratios, 95% CI, and Wald p values were calculated. Follow-up sta rted at 
enrolment and patients were censored at the earliest date of the following: first TB diagnosis, 
. last follow-up visit, death, withdrawal from the cohort, or December 31, 2013. We considered 
events contributing to the follow up if they happen within the period of registration(eg events 
only count for patients registered prior to 2013 if they happen prior to 2013). We conducted a 
cOlllplete case analysis for all variables in the Illultivariate analysis and for variables with more 
than 10% of records missing were assessed in the llnivariable analysis but not included in the 
multi variable models. The characteristics of patients with and without missing records for such 
variables we re compared to assess potential systematic differences between patients with and 
without missing data. The choice of confounders was made based on literature review and clin-
ical knowledgeand aU predictors were selected apriori and included in the final 
multi variable model. 
Finall y, a sens itivity analysis was done in order to est imate the impact of the bundelon early 
diagnosis and diagnosis on new cases. First we estimated the rate of ascertainment on only pa-
tients diagnosed within a month of registration and second est imating rate by excluding those 
diagnosed within the first month of registration. Data were extracted. processed and analysed 
using SAS v9.3 (SAS Institute. North Caroline. USA) and STATA vl 2 (StataCorp, Texas, 
USA). 
Results 
A total of7114l-I IV- infected pat ients were enrolled in the KIULARCO cohort between January 
2005 and December 2013. Of these, 5123 were eligible for the study (Fig 1). At the lime of en-
rolment, the median age was 38 years (Interquartile range (lQR): 30.6, 46) and median CD4 
count was 243 cells/~1 (lQR: 102,477). Sixty-six percent were female, 45% were married and 
92% were residents of the Kilombero district. Late presentation was common with 27% and 
16% enrolling with WHO stage 3 and 4 respectively. and 63% with ::; 350 CD4 cells/~1. Six per-
cent of patients were on ART at enrolment and 84% started ART during follow-up, with 80% 
report ing good adherence. Social demographic and clinical characteristics of the study popula-
tion did not differ with those of the entire cohort (TabkJ). 
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Fig 1. Flow diagram of the study population. 
doi: 1 O.1371fjournal.pone.OI23275.g001 
Table 1. Summary of the baseline characteristics of study participants. 
Pre 2013 
2012 2014 
Post 2013 
Characteristic Study population Eligible population Study population Eligible population 
(N = 6622) (N = 4772) (N = 492) (N =351) 
Age (years), median (lOR) 38.1 (30.6-46.1) 38.2 (30.6-46) 36.2 (29.6-45.4) 36 (29.8-45.6) 
Male Gender, n (%) 2403 (36.6) 1610 (33.9) 168 (34.2) 110 (31.3) 
WHO clinical stage, n ('Yo) 
Slage II I/IV 2204 (52) 1357 (41.8) 265 (55.5) 180 (51.9) 
CD+4 cell count, n ('Yo) 
Median (lQRleens/ul 228 (91-449) 242 (102.7-477) 201 (66.5-418.5) 201 (67-387) 
$.35OcellS/ul 1501 (65.4) 938 (62.7) 304 (69.1) 230 (7 1.4) 
On ART during follow-up. n (%) 4970 (83.7) 4034 (84.6) 301 (61.2) 260 (74.1) 
Functional status, n (%) 
Working 5142 (89.3) 4214 (91.5) 416 (85.1) 313 (89.7) 
Ambulalory 502 (8.7) 308 (6.7) 52 (10.6) 25 (7.2) 
Bedridden 109 (2) 83 (1.8) 21 (4.3) 11 (3.1) 
Alcohol use, n (%) 1603 (27.7) 1127 (27.8) 77 (15.6) 53 (15.1) 
Smoking, n (%) 894 (15.4) 601 (14.8) 14 (2) 8 (2.3) 
History of chronic diseases, n (%) 942 (15.7) 673 (15.9) 6 (1 .2) 4 (1.1) 
Percentages exclude missing values: Chronic diseases include arterial hypertension, diabetes mellitus and cancer. KIULAACO: Kilombero Ulanga 
Antiretroviral Cohort; lOA: Inlerquartile range; WHO: World Health Organization. ART: Anlirelrovirallreatment 
doi: 10.1371fjournal.pone.D123275.1001 
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Tota l number of HIV patients 
enrolled in KIULARCO 
N = 7114 
1991- Total number excluded 
718 - no follow up visit 
1167 - history of previous T8 
Eligible patients 67 - referral from T8 dinic 
N = 5123 39 - on anti-T8 medication 
• 
TB cases reported at least once during T8 was not reported during follow up follow up 
N =421 
N = 4702 
Fig 2. Incidence rate of tuberculosis ascertainment over time, 2005-2013. 
doi:10.1371!joumal.pone.0123275.g002 
Tuberculosis ascertainment 
In total 421 TB cases were registered in the KIULARCO cohort between 2005 and 2013. Of 
these 81 had been registered in 2013. and 47 af the patients registered prior to 2013 developed 
TB in 20 13. Thus, 128/42 1 (30%) TB cases were diagnosed in 2013. GeneXpert contributed to 
12% (151128) of all TB diagnostics in 201 3. 
The overall person-years (p-y) of follow-up was 11,323 (1 1,149 p.y prior to 2013 and 175 p-
Y post 2013) and the incidence rate of TB ascertainment was 3.60 per 100 p-y (95% CI: 3.26-
3.97) during the study period. The incidence rate before 2013 was 2.96 per 100 p-.y (95% Cl: 
2.66-3.30) and 43.98 per 100 p-y (95% Cl: 35.18-54.99) during 2013 (!'ig].). The incidence 
rate ofTB was higher among males (3.98 per 100 p-y; 95% CI: 3.38- 4.67), patients aged < 18 
years (4.40 per 100 p-y; 95% CI: 3.3 1-5.83), ART naive individuals (7.67 per 100 p-y 95%CI 
6.28-9.37) and those with baseline WHO cl inical stage 3 or 4 (8.30 per 100 p-y; 95% CI: 7.27-
9.46. Table 2). 
During the same period, 1868 TB cases were reported from Saint Francis Referral Hospital 
to the National Tuberculosis and leprosy programme (NTLP). Of them, 1363 (73%) were pul-
monary TB and 505 (27%) extrapulmonary. Only 27% of pulmonary cases were confirmed 
through microscopy smear. In 2013, 84% (1411167) of all TB/HIV cases reported to the NTLP 
from our hospital were captured in the KIULARCO database as compared with 16% (2801 
1701) prior to 2013. 
Predictors of tuberculosis ascertainment 
In univariate analysis, being single, WHO clinical stage 3 or 4, having a poor functional status 
at baseline (being bedridden or unable to work), CD4 count ::;350 cells/~l1. ART-naivety, and 
registration in 2013 versus pre-2013 were associated with an increased rate ofTB recording in 
the KIULARCO database. 
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Table 2. Incidence rates of Tuberculosis ascertainment among HIV patients enrolled in KIUlARCO per selected characteristics. 
Characteristics Overall Incidence 9s%CI P value Early Incidence 95%CI P value Incidence rate one 95%CI P va lue 
rates (per 100 rates (per 100 month after registration 
person years) person years) (per 100 personyea rs) 
Sex 
Female 3.43 3.03-3.87 0.06 0.88 0.69-1.12 0.08 2.55 2.21-2.93 0.26 
Male 3.98 3.38- 4.67 1.23 0.92-1.65 2.75 2.13-3.12 
Age group 
Adults ~ 1 8 3.50 3.15-3.89 0.21 0.95 0.78-1.16 0.2 2.55 2.28-2.89 0.48 
Children<18 4.40 3.31-5.83 1.37 0.82-2.28 3.02 2.15- 4.25 
WHO clinlcalstage 
1 and 2 2.31 1.91-2.81 <0.0001 0.46 0.31HJ.71 <0.0001 1.85 1.49-2.29 <0.0001 
3and 4 8.30 7.27-9.46 2.80 2.23-3.51 5.51 4.68- 6.47 
ART treatment 
No 7.67 6.28-9.37 <0.0001 4.07 3.10-5.36 <0.0001 3.63 2.71-4.86 0.1 
Ves 3.09 2.77-3.46 0.61 0.47-0.78 2.48 2.19-2.81 
Smoking 
No 3.36 3.00-3.77 0.92 1.04 0.84-1.28 0.06 2.32 2.02-2.66 0.18 
Ves 3.66 2.73-4.91 0.57 0.27-1.19 3.10 2.26-4.27 
History of any chronic 
disease 
No 3.32 2.97-3.72 0.32 0.97 0.78-1.19 0.39 2.36 2.06-2 .70 0.54 
Ves 3.63 2.63-5.01 1.07 0.59-1.94 2.56 1.74-3.76 
Perlodofregislration 
(years) 
Before 2013 2.96 2.66-3.30 <0.0001 0.57 0.44-0.73 <0.0001 2.39 1.93-2.46 <O.OOOt 
2013 43.98 35.18- 27.99 21.15- 16.36 11.29-
54.99 37.03 23.69 
Chronic diseases include arterial hypertension, diabetes mellitus and cancer. T8: tuberculosis; Confidence interval; WHO: World Health Organization; 
ART: Anlirelroviral lrealmenl 
dOi:10.1371fjourna1.pone.0123275.IOO2 
Four baseline independent predictors of increased risk ofTB ascertainment were identified 
in the multivariate analysis: registration in 2013 (HR 6.07. 95% CI: 4.39- 8.38), WHO stage 3 or 
4 (HR 2.48, 95% CI: 1.88- 3.26), poor functional status at baseline (HR 3.89, 95% CI; 2.87-
5.28), and ART-naivety (HR 2.97, 95%CI 2.25-3.94), Table 3). 
Early tuberculosis diagnosis 
In total 126 TB cases were recorded in KIULARCO within a month after enrolment, 73 pre-
and 53 post·20 12. Seventy-five percent (55173) and 8 I % (43153) of those diagnosed before and 
after 20 12 respectively were ART -na·ive. The overall rate of early diagnosis pre-20 13 was 0.57 
cases per 100 p-y (95% CI 0.44-0.73) and 28 per 100 p-y (95% CI 21.1 5- 37.03) in 20 13 
(p< O.OOO I) . Early diagnosis was higher among ART -naive compared to those on ART (4.07 
per 100 p-y (95% CI 3.10-5.36) vs 0.61 per 100 p.y (95% CI 0.47-0.78) respectively). Indepen-
dent predictors of early diagnosis did not differ from those of the entire cohort. 
Discussion 
Tn this large study including 5123 HIV infected patients enrolled in a rural African HIV pro-
spective cohort between 2005 and 2013. the previously stable TB incidence rate dramatically 
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Table 3. Cox regression analysis of risk factors for tuberculosis ascertainment by period. 
2005-2013 Pre-2013 Post 2013 
Characteristics Unadjusted hazard 
ratio (95% e l) 
Gender 
Female 1 
Male 1.20 (0.98-1.48) 
Age group (years) 
'2: 18 1 
<18 1.31 (1.07-1.61) 
Marital status 
Married 
Not Married 1.31 (1.07- 1.61) 
WHO stage 
1/11 
II I/IV 3.22 (2.54-4.06) 
ART 
Ves 1 
No 2. 12 (1.69-2.67) 
Smoking 
No 1 
Ves 1.01 (0.74-1.39) 
Chronic diseaseD 
No 
Ves 6.30 (4.83-8.2 1) 
Functional status 
Working 1 
Ambulatory or 6.20 (4.9()"7.83) 
bedridden 
Registration (year) 
Before 2013 1 
2013 6.30 (4.83-8.21) 
doi:l 0.1371 fjourna1.pone.0123275.tOO3 
Adjusted hazard Unadjusted hazard Adjusted hazard Unadjusted hazard Adjusted hazard 
ratio (95%CI) ratio (95% el) ratio (95%CI) ratio (95% Cll ratio (95%CI) 
1 1 1 1 1 
1.12 (1.85-1.47) 1.11 (0.89-1.40) 0.93 (0.67- 1.31) 1.97 (1.25-3.09) 1.72 (1.02-2.87) 
1 1 
1.02 (0.68- 1.50) 1.03 (0.72-1.46) 1.03 (0.65-1.65) 2.67 (1.50-4.80) 1.24 (0.57-2.68) 
1 1 1 1 
1.27(0.97-1.66) 1.21 (0.95-1.52) 1.15 (0.84-1.57) 2.41 (1.48--3.90) 1.35 (0.77-2.34) 
1 1 1 
2.48 (1.88-3.26) 2.82 (2 .17-3.66) 1.94 (1.43-2.65) 4.50 (2.58-7.83) 3.97 (2.14-7.32) 
1 1 1 1 1 
2.97 (2.25-3.94) 1.12(0.82-1 .53) 1.42 (0.94-2.13) 9.35 (5.8()"15.1) 11.1 (6.5-1874) 
1 1 
1.21 (0.81-1.82) 1.27 (0.91-1.77) 1.28 (0.83-1.96) 1.20 (0.29-4.90) 1.90 (0.43-8.34) 
1 1 1 1 
1.36 (0.92- 1.99) 1.09 (0.75-1.56) 1.50 (1.01-2.21) 0.91 (0.13-6.52) 1.50 (0.19-11 .27) 
1 1 1 
3.89 (2.87-5.28) 6.59 (5.07-8.57) 4.80 (3.35-6.83) 4.44 (2.64-7.46) 
1 
6.07 (4.39-8.38) 
increased after the introduction of a bundle of services consisting of the integration of HI V and 
TB services within one single facility, use of GeneXpert, and implementation of an electronic 
data collection system. In addition, the bundle of services had an impact on early detection of 
TB among ART naIve patients. Moreover the strongest predictor ofTB identified was registra-
tion in the cl in ic after the introduction of the bundle of services. To our knowledge this is the 
first report to show the impact of such a bundle of services on tuberculosis ascertainment in Af-
rica. Previous studies on trends ofTB case not ification in Africa have indicated a decrease in 
trend among HIV patients fo llowing scaling lip of ART [.2.,2.]. We implemented system changes 
which emphasize intensificat ion of screening for Til among HIV patients and optimized data 
recording which resulted into ident ifying more TB incident cases. Thus, our findings suggest a 
potential under-diagnosis and/or under-reporting ofTB among HIV infected individuals in 
similar rural African settings. 
Our findings concur with previous studies from sub-Saharan Africa showing an increase of 
TB diagnosis when Til and HIV programs are integrated and TB screening intensified[9- 111. 
Integration of both programs in one single health facility provides an opportunity for early 
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diagnosis of HI V among Til patients as well as early diagnosis ofTB among HIV patients[9J. 
Different models have been implemented to integrate TB and HIV care, ranging from models 
induding referrals between the two dinics to more comprehensive models offering care under 
one facility[l1J The latter, though demanding in organizational and administrative structure, 
has proved to be more effective [1 2J. However, some challenges exist including training and re-
tention of staff, and infection control[U]. 
GeneXpert has been shown to have a high sensitivity and specificity for TB diagnosis [Z,IJ]. 
Previolls studies in high burden countries have indicated an increase in TB case reporting 
when GeneXpert was used compared to sputum microscopy[Z,14-J6j. Vassal! A (2011) et 11.1 
observed an overall increase in TIl detection in India, South Africa and Uganda from 72%-85% 
to 95%-99% lJ.1). Results from a decision model study from South Africa on impact of national 
scaling lip suggested a potential 30%-37% increase in the number ofTB cases diagnosed per 
year[17). Another study in the same setting indicated an increase of 45% in HIV associated TIl 
detection when GeneXpert was used compared to smear microscopy[ 1 51. However, the value 
ofGeneXpert in high TB burden settings where empirical treatment is common has been re-
cently questioned, suggesting that in these settings wide GeneXpert use may displace empirical 
treatment instead of improving outcomes and disease burden [18}. Empi rical treatment at the 
CDCI was initiated after negative microbiological tests, a course of antibiotics without effect, 
and a radiography suggestive ofTB. We observed an increase of almost fifteen-fold in the rate 
ofTB ascertainment after introduction of the bundle of services including GeneXpert use. 
However, our findings of an increased TB ascertainment do not seem to be fully explained by 
the use of GeneXpert, since it only accounted for 12% of additional TB cases detected in 20 13. 
Previous studies have reported that the use of electronic system in medical records help im-
prove health care quality in general and for HIVI AIDS patients [t2.-22J. We replaced the previ-
ous paper-based system with the electronic system, which prompts clinicians to inquire and 
report all required information. Specifically, clinicians are compelled to collect information on 
the screening of symptoms and signs ofTB in every visit and report the cases using lCD- I 0 
codes. TB screening among all HIV -infected individuals attending the clinic is currently per-
formed at all visits and all TB patients are in turn routinely screened for HIV. This suggests 
that the observed increase in incidence rates ofTB ascertainment was partly due to changes in 
recording systems as well as improved clinical information collection tools. Indeed, 84% of all 
TB/HIV cases recorded at the National TuberClllosis and Leprosy Programme (NTLP) from 
our hospital were captured in the KIULARCO database 2013a 68% increase from the period 
prior to 2013. 
There are limited data on the incidence ofTB notification among HIV patients in Tanzania. 
The latest estimates of prevalence of TIl by the WHO and the Tanzanian Ministry of Health 
are 177 per 100,000 persons and 295 per 100,000 persons respectively among the general popu-
lation [26,ll j. In 2013, we obtained an overall est imated incidence notification rate of 44 cases 
per 100 p-y. Due to the lack of comparative studies in similar populations, our findings provide 
relevant information to assess the incidence rates ofTB among HIV patients in Tanzania. 
However, this incidence rate is high compared to previolls estimations from SOllth Africa (9.2 
cases per 100 person-years)[28). Importantly, despite acknowledging a potential overestima-
tion, our findi ngs reflect the incidence of tuberculosis in a "real-life" rural African setting, with 
a high proportion of clinical diagnosis and empiric treatment. The incidence ofTB diagnosis in 
children was estimated to be 4.4 per 100 p-y slightly, similar to previolls results from Dar es Sa-
laam (5.2 per 100 p-y)[29J. As expected, we observed a lower rate ofTB notification among 
those who were on ART compared to ART-naive patients. concurring with a number of studies 
showing reduction in the risk ofTB among HIV patients on ART[30-35J. Remarkably, we also 
observed an increase in early TB notification after implementing system changes. Eighty one 
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percent of patients diagnosed early in 2013 were ART na"ive at the time afTB diagnosis. CO I11-
pared to 75% pre-20l3. Increasing TB notification among ART-naYve individuals has impor-
tant clinical implicat ions, reducing the incidence of immune reconstitution inflammatory 
syndrome (IRIS), and increasing surviva \[36.J. 
Four baseline factors were identified as independent predictors ofTB, including W HO clini -
cal stage 3 or 4. ART naivety, poor functional status. and registration in 2013. There were not 
remarkable differences in predictors ofTB ascertainment between pre- and post 2013. Our 
findings are similar to those by IIliyasu Z et fli. in which marital status, WHO stage and C04 
+ count predicted TB occurrence [37]. We did not include C04+ count in the multivariable 
model due to sign ificant missing values, which would have resulted into an unstable model. 
However, we presented the univariable estimates that suggested that C04+ count was an im-
portant predictor ofTB notifica tion in our population. An attempted sensitivity analysis by in-
cluding missing values all C04+ count through imputation of the mean did not modify the 
results and the rate ofTB notification was still higher among those with CD4+ count 
::;350cells/~1. Remarkably, registration in 2013 was the strongest predictor ofTB notification 
even after excluding early TB notification in sensitivity analysis, suggesting a critica l role of the 
bundle of services introduced in December 20 12. 
This study has certain limitations. First, due to the combined introduct ion of the three inter-
ventions, the improvement in TB ascerta inment could not be attributed to any part icular inter-
vention but to the bundle of services. However, support ing o ther obselVations, GeneXpert does 
not seem to have played a p romi nent role in increasing Tn ascertainment. Second, a longe r fol -
low*up will be needed to measure the long·term impact of this strategy. Despite the exten t of 
miss ing values on baseline WHO clinical stage and CD4+ count being more than 10%, it is un-
likely that our study populat ion was biased due to missing data since the characteristics of the 
study population and that of the whole cohort did not differ. Third, we acknowledge that the 
in fluence of other factors such as changes in clinical administration and motiva tion of clini -
cians may have contributed. However, these factors are not easily measured. Fourth, our find -
ing~ indicate an increase in diagnosis ofTB within the KIULARCO cohort, but it has been 
difficult to es timate accurately whether the impact of this bundle of selv ices also result ed in an 
increased notification to the Nat ional Tuberculosis and Leprosy Program. Finally, we recognize 
the potential for information bias and record error, since tuberculosis cases for this study were 
entirely based on records in the database. 
There are several clinical and public health implications of our findings, particularly in light 
of the striking disparity in TB ascertainment and reporting before and after the implementation 
of the bundle of selVices in our clin ic. First, our results support the need for a switch from verti· 
cal models to comprehensive ca re models in rural sub~Saharan Africa. The integration ofTB 
and HIV selVices within one single facility is a first step in this direction . This integration al-
lowed for the systematic application of diagnostic algorithms including clinical information, 
chest radiography, and a true point-of-care use of GeneXpert, providing results in less than two 
hours, and decreasing the waiting time and travel expenses for our patients. GeneXpert is being 
progressively rolled out in sub-Saharan Africa, but as important as its roll out is the adaptation 
of the health fac ilities to this new technology and its full integration within the existing routine 
diagnostic algorithms to maximize its potential benefits. Second, Ollr findings stress the several 
advantages of the replacement of cl inic logs with electronic medical records, which we believe 
should be a public health priority in these settings to optimize clinical efficiency and epidelllio~ 
logical sUlVeillance. Finally our results suggest the possib ility of an under·ascertainment of 
TB-HIV in similar settings in Tanzania and other Sub·$.1haran African countries. TB is the first 
cause of death among HIV *infected patients in Africa, and can be fatal if non-diagnosed and 
treated timely. Moreover, ART initiation in non+diagnosed active T B cases may result in the 
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development of unmasking T B-IRIS. posing a tremendous clinical challenge to clinicians in 
these settings and carrying significant morbidity and mortality if not properly managed. 
In summary. we believe that in tegrating tuberculosis and HIV services together with a COI11 -
prehensive electronic data collection and use of appropriate diagnostic tools are pivotal in as-
sessing the burden of tuberculosis among Hrv -positive patients and may contribute to 
decrease the unacceptably high HIV -TB-associated mortality in Africa. Further studies to as-
sess the potential effects of similar strategies on this and other clinical outcomes are warranted. 
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